About Bioct
Bioct is a Healthcare company based in United States. Bioinformatics resources and training are provided for biological research. Its website bioct.org draws about 11 thousand monthly visits. Its focus areas include Medical Research Labs.
Company details
Bioinformatics tools and educational materials are offered by Bioct in the United States, focusing on biological data analysis. Sequence alignment, gene expression, and phylogenetic analysis are supported through its resources. Training programs are conducted to build skills among researchers and students. Operations emphasize accessible support for advancements in the bioinformatics sector, with services delivered via online platforms.
- Headquarters United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website bioct.org
- Latest Funding Round$1.04M (USD), Grant
Jun 2007
- Investors
Funding Insights of Bioct
- Total Rounds 1
- Last Round Grant — $1.04M
- First Round $1.04M
(Jun 2007)
- Investors Count 1
All 1 funding rounds of Bioct with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | $1.04M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Bioct
Bioct has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Bioct
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bioct
16 people are tracked at Bioct (4 in leadership, 12 in board & advisors).
| Name | Role | Group |
|---|---|---|
Jodie Gillon | President & CEO | Leadership |
Kimberly Nash Kelly | Vice President, Bioct Incubators | Leadership |
kelley gipson | Chief Operating Officer | Leadership |
Jodie Sherman Gillon | President & Chief Executive Officer | Leadership |
J. Dormer Stephen | Director | Board & advisors |
Raja Mangipudy | Director | Board & advisors |
Abhijit Banerjee | Director | Board & advisors |
Josh Geballe | Director | Board & advisors |
Kaile Zagger | Director | Board & advisors |
Stanley Choy | Co-Chair & Treasurer | Board & advisors |
Paul Hughes | Secretary | Board & advisors |
Robert Bettigole | Director | Board & advisors |
John G. Houston | Director | Board & advisors |
Cynthia D. Green | Director | Board & advisors |
Erika Smith | Director | Board & advisors |
David I. Scheer | Director | Board & advisors |
Complete people profiles for Bioct
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Bioct
The website of Bioct (bioct.org) receives about 11K visits a month and ranks #2,362,632 among all websites worldwide, #3,233 in Biotechnology and Pharmaceuticals.
- Monthly visits11K
▲ 43.9% vs previous month
- Unique visitors3.5K
per month
- Global rank#2,362,632
among all websites
- Category rank#3,233
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit2.6
- Average visit59 sec
- DevicesDesktop 38% · Mobile 62%
Websites whose visitors overlap most with Bioct. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nucleate.org | nucleate.org | 100% | #654,247 | – | |
| pfizerforall.com | 93% | #519,521 | View details | ||
| arvinas.com | 92% | 11.1K | #1,825,332 | View details | |
| pangolintherapeutics.com | 29% | View details |
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as Bioct (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | 22 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioct
Bioct is headquartered in United States.
Bioinformatics tools and educational materials are offered by Bioct in the United States, focusing on biological data analysis. Sequence alignment, gene expression, and phylogenetic analysis are supported through its resources. Training programs are conducted to build skills among researchers and students. Operations emphasize accessible support for advancements in the bioinformatics sector, with services delivered via online platforms.
Bioct has 1 investor. Key investors include HHS.